Daniel Camardo, MBA

Daniel Camardo, MBA, Chief Executive Officer

Mr. Camardo joined Athersys in February 2022 as our Chief Executive Officer. Prior to him joining the team, Mr. Camardo served as Executive Vice President and Head of the Rare Disease and Inflammation Business Units and President, U.S. at Horizon Therapeutics (Horizon). In this previous role, Mr. Camardo led a broad commercial transformation, built out new capabilities to support a portfolio of products in the rare disease and specialty medicines space, and helped transform the small specialty products company into a global biotechnology company focused on rare, autoimmune, and severe inflammatory diseases. He has worked in commercial leadership roles for other biotechnology and pharmaceutical companies, including Astellas and has been involved in more than 10 medicine launches across various therapeutic areas, including small molecules and biologics. Mr. Camardo is recognized for creating innovative solutions to overcome marketplace challenges and fostering cross-functional collaboration to drive results. Mr. Camardo holds a Bachelor of Arts degree in Economics and Mathematics from the University of Rochester and a Master of Business Administration from Northwestern University’s Kellogg School of Management.